GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InDex Pharmaceuticals Holding AB (OSTO:INDEX) » Definitions » Cash Payments

InDex Pharmaceuticals Holding AB (OSTO:INDEX) Cash Payments


View and export this data going back to 2016. Start your Free Trial

What is InDex Pharmaceuticals Holding AB Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.


InDex Pharmaceuticals Holding AB (OSTO:INDEX) Business Description

Traded in Other Exchanges
N/A
Address
Berzelius vag 13, Solna, SWE, 171 65
InDex Pharmaceuticals Holding AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The company's main asset is the drug candidate cobitolimod, which is being evaluated in the phase III study as a treatment for moderate to severe ulcerative colitis - a disabling, chronic inflammation of the colon. It has also developed a platform of patent-protected substances, so-called DNA-based Immunomodulatory Sequences, with the potential to be used in the treatment of various immunological diseases.